LONDON--(BUSINESS WIRE)--
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | ||||
| Company dealt in | CHIQUITA BRANDS INTERNATIONAL INC | ||||
| Class of relevant security to which the | $0.01 common shares | ||||
| dealings being disclosed relate (Note 2) | |||||
| Date of dealing | 30 September 2014 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | $0.01 common shares | ||||||||||
| Long | Short | ||||||||||
| Number | (%) | Number | (%) | ||||||||
| (1) | Relevant securities | ||||||||||
| 551,592 | 1.17% | 9,984 | 0.02% | ||||||||
| (2) | Derivatives (other than options): | ||||||||||
| 0 | 0.00% | 0 | 0.00% | ||||||||
| (3) | Options and agreements to | ||||||||||
| purchase/sell: | 17,400 | 0.04% | 8,500 | 0.02% | |||||||
| TOTAL: | |||||||||||
| 568,992 | 1.21% | 18,484 | 0.04% | ||||||||
| Class of relevant security: | 4.25% convertible senior notes due 2016 | ||||||||||
| Long | Short | ||||||||||
| Number | (%) | Number | (%) | ||||||||
| (1) | Relevant securities | ||||||||||
| 2,000 | 0.00% | 0 | 0.00% | ||||||||
| (2) | Derivatives (other than options): | ||||||||||
| 0 | 0.00% | 0 | 0.00% | ||||||||
| (3) | Options and agreements to | ||||||||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||||||
| TOTAL: | |||||||||||
| 2,000 | 0.00% | 0 | 0.00% | ||||||||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Class of relevant security: | Long | Short | ||
| Number (%) | Number (%) | |||
|
(1) Relevant securities |
||||
|
(2) Derivatives (other than options) |
||||
|
(3) Options and agreements to purchase/sell |
||||
|
Total |
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit | |||
| Purchase | 42 | 14.2400 USD | |||
| Purchase | 300 | 14.2100 USD | |||
| Purchase | 500 | 14.2800 USD | |||
| Purchase | 1,400 | 14.3063 USD | |||
| Purchase | 1,400 | 14.3289 USD | |||
| Purchase | 1,726 | 14.2000 USD | |||
| Sale | 60 | 14.3900 USD | |||
| Sale | 101 | 14.2901 USD | |||
| Sale | 140 | 14.2800 USD | |||
| Sale | 200 | 14.2155 USD | |||
| Sale | 200 | 14.3000 USD | |||
| Sale | 200 | 14.3400 USD | |||
| Sale | 200 | 14.3600 USD | |||
| Sale | 250 | 14.3320 USD | |||
| Sale | 300 | 14.3466 USD | |||
| Sale | 400 | 14.3550 USD | |||
| Sale | 500 | 14.3100 USD | |||
| Sale | 500 | 14.3200 USD | |||
| Sale | 550 | 14.3081 USD | |||
| Sale | 800 | 14.3500 USD | |||
| Sale | 1,200 | 14.3074 USD | |||
| Sale | 1,200 | 14.3215 USD | |||
| Sale | 5,194 | 14.2000 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD |
Nature of transaction
(Note 6) |
Number of relevant securities
(Note 7) |
Price per unit
(Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature of transaction
(Note 8) |
Details |
Price per unit
(if applicable) (Note 5) |
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
| Is a Supplemental Form 8 (Open Positions) attached? | YES | ||
| Date of disclosure: | 1 Oct 2014 | ||
| Contact name: | Rajesh Muthanna | ||
| Telephone number: | 020 3555 4634 | ||
| If a connected EFM, name of offeree/offeror with which connected | |||
| If a connected EFM, state nature of connection | |||
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry | ||||||
| purchased | relevant securities | price | date | ||||||||
| to which the option | |||||||||||
| or derivative | |||||||||||
| relates | |||||||||||
| Call Options | Purchased | 5,000 | 14.0000 | American | 18 Oct 2014 | ||||||
| Call Options | Purchased | 10,700 | 14.0000 | American | 22 Nov 2014 | ||||||
| Call Options | Purchased | 100 | 14.0000 | American | 20 Feb 2015 | ||||||
| Call Options | Purchased | 100 | 15.0000 | American | 20 Feb 2015 | ||||||
| Call Options | Purchased | 100 | 17.0000 | American | 20 Feb 2015 | ||||||
| Call Options | Written | -2,500 | 11.0000 | American | 22 Nov 2014 | ||||||
| Put Options | Purchased | -400 | 12.0000 | American | 20 Feb 2015 | ||||||
| Put Options | Purchased | -2,700 | 13.0000 | American | 22 Nov 2014 | ||||||
| Put Options | Purchased | -2,000 | 13.0000 | American | 20 Feb 2015 | ||||||
| Put Options | Purchased | -500 | 14.0000 | American | 22 Nov 2014 | ||||||
| Put Options | Purchased | -400 | 16.0000 | American | 22 Nov 2014 | ||||||
| Put Options | Written | 1,400 | 13.0000 | American | 18 Oct 2014 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.